A Importância do farmacêutico clínico nos tempos de pandemia correlacionado as interações medicamentosas em Açailândia-MA
Authors:
- Nayranna Chrystina Sobrinho Costa de SousaNSNayranna Chrystina Sobrinho Costa de Sousa
- Vinycius Manoel Sobrinho Costa de SousaVSVinycius Manoel Sobrinho Costa de Sousa
- Francisco Alves Lima JuniorFJFrancisco Alves Lima Junior
- Patrícia dos Santos Silva QueirozPQPatrícia dos Santos Silva Queiroz
- Karla Vanessa Morais LimaKLKarla Vanessa Morais Lima
- Flávio Silva de CarvalhoFCFlávio Silva de Carvalho
- Enderson Sousa FernandesEFEnderson Sousa Fernandes
- Benedita Maryjose Gleyk GomesBGBenedita Maryjose Gleyk Gomes
- Caroline Amélia GonçalvesCGCaroline Amélia Gonçalves
- Antonio Silva MachadoAMAntonio Silva Machado
Open Access
- 8 November 2022
- journal article
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (15)
Abstract
Given that the COVID-19 pandemic has brought about a major problem in world health, it has led to a greater performance of health professionals, including pharmacists, due to the high demand in the provision of health services in an individualized and collective way in pharmacotherapy and health education. SARS-CoV-2 is contagious, manifesting itself in a severe acute form, characterized as severe acute respiratory syndrome (ARDS), where symptoms are similar to other viral infections, with variability of transmissibility from individual to individual. Research is carried out on drug interactions during the pandemic in Açailândia-MA, in order to point out the importance of the clinical pharmacist during the pandemic scenario. Therefore, it is necessary to analyze the drug interactions that are recurrent in the treatment of COVID-19 and compile the problem of self-medication during the pandemic. Field research is carried out using medical prescriptions. In view of this, it appears that the results presented from 248 medical prescriptions result in antimicrobials (n=280), antiparasitics (n=138) and vitamins (n=128) prescribed, observing their interactions by severity, highlighting moderate in 96, 3% in higher percentage. What imposes the observation is that the pharmacist becomes the essential professional in the quality of life of the patient, being able to optimize the pharmacological treatment and improve health and adherence to pharmacotherapy.Keywords
This publication has 14 references indexed in Scilit:
- Human coronavirus spike protein-host receptor recognitionProgress in Biophysics and Molecular Biology, 2021
- Research progress on coronavirus S proteins and their receptorsArchives of Virology, 2021
- Fighting against COVID-19: Innovative strategies for clinical pharmacistsResearch in Social and Administrative Pharmacy, 2021
- Pathogenesis‐directed therapy of 2019 novel coronavirus diseaseJournal of Medical Virology, 2020
- The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”Inflammation Research, 2020
- Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)The Journal of Pathology, 2020
- Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020
- COVID-19 in children and altered inflammatory responsesPediatric Research, 2020
- Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19Journal of Medical Virology, 2020
- Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational studyWorld Journal of Pediatrics, 2020